Does Clinical Response Correlate With Serum Certolizumab Levels?
Status unconfirmed · Phase 4
Conditions studied: Crohn's Disease
In brief
A prospective open label trial of adult patients with active Crohn's disease to determine if plasma concentrations of certolizumab pegol correlate to mucosal healing.
Key facts
- Study ID
- NCT02597829
- Run by
- Shafran Gastroenterology Center
- People needed
- 20
- Starts
- 2015-11-01
- Expected to finish
- 2018-10-01
- Last updated by the study team
- 2015-11-05
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Shafran Gastroenterology Center — Winter Park, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.